Solid Tumor, Adult

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

Intravital Microscopy in Human Solid Tumors

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies

A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

A Study of ATTR-01 in Participants With Select Epithelial Solid Tumours

First In Human Study of CX-2051 in Advanced Solid Tumors

A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer

First In Human Study of CX-801 in Advanced Solid Tumors

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

COAST Therapy in Advanced Solid Tumors and Prostate Cancer

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

DT-9081 Study in Participants With Advanced, Recurrent or Metastatic Solid Tumours

A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors

UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations